Cargando…

Timing of antibiotic therapy in the ICU

Severe or life threatening infections are common among patients in the intensive care unit (ICU). Most infections in the ICU are bacterial or fungal in origin and require antimicrobial therapy for clinical resolution. Antibiotics are the cornerstone of therapy for infected critically ill patients. H...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kollef, Marin H., Shorr, Andrew F., Bassetti, Matteo, Timsit, Jean-Francois, Micek, Scott T., Michelson, Andrew P., Garnacho-Montero, Jose
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8518273/ https://www.ncbi.nlm.nih.gov/pubmed/34654462 http://dx.doi.org/10.1186/s13054-021-03787-z

Ejemplares similares

1658 C. difficile Recurrence is a Strong Predictor of 30-day Rehospitalization Among ICU Patients
por: Zilberberg, Marya D., et al.
Publicado: (2014)

Predictors of hospital mortality among septic ICU patients with Acinetobacter spp.bacteremia: a cohort study
por: Shorr, Andrew F, et al.
Publicado: (2014)

718 Predictors of Hospital Mortality Among Septic ICU Patients With Acinetobacter spp. Bacteremia: A Cohort Study
por: Shorr, Andrew F., et al.
Publicado: (2014)

Inappropriate empiric antifungal therapy for candidemia in the ICU and hospital resource utilization: a retrospective cohort study
por: Zilberberg, Marya D, et al.
Publicado: (2010)

Multi-drug resistance, inappropriate initial antibiotic therapy and mortality in Gram-negative severe sepsis and septic shock: a retrospective cohort study
por: Zilberberg, Marya D, et al.
Publicado: (2014)

Antimicrobial de-escalation is part of appropriate antibiotic usage in ICU
por: Timsit, Jean-Francois, et al.
Publicado: (2020)

Bacterial and fungal superinfections in critically ill patients with COVID-19
por: Bassetti, Matteo, et al.
Publicado: (2020)

Outcomes associated with bacteremia in the setting of methicillin-resistant Staphylococcus aureus pneumonia: a retrospective cohort study
por: Shorr, Andrew F., et al.
Publicado: (2015)

Viruses are prevalent in non-ventilated hospital-acquired pneumonia
por: Shorr, Andrew F., et al.
Publicado: (2017)

Principles of antimicrobial stewardship for bacterial and fungal infections in ICU
por: Bassetti, Matteo, et al.
Publicado: (2017)

Assessment of risk factors for inappropriate empiric antibiotic therapy in patients with Gram-negative sterile site infection complicated by sepsis or septic shock
por: Micek, Scott, et al.
Publicado: (2017)

Ceftriaxone resistance and adequacy of initial antibiotic therapy in community onset bacterial pneumonia
por: Van Besien, Richard F., et al.
Publicado: (2022)

Azithromycin and survival in Streptococcus pneumoniae pneumonia: a retrospective study
por: Shorr, Andrew F, et al.
Publicado: (2013)

Lack of pathogen identification influencing antibiotic de-escalation in hospital-acquired pneumonia
por: Bittmann, Matthew C., et al.
Publicado: (2022)

A cohort study of bacteremic pneumonia: The importance of antibiotic resistance and appropriate initial therapy?
por: Guillamet, Cristina Vazquez, et al.
Publicado: (2016)

An institutional perspective on the impact of recent antibiotic exposure on length of stay and hospital costs for patients with gram-negative sepsis
por: Micek, Scott, et al.
Publicado: (2012)

Antimicrobial stewardship programs: mandatory for all ICUs
por: Kollef, Marin H, et al.
Publicado: (2012)

Adequate antibiotic therapy prior to ICU admission in patients with severe sepsis and septic shock reduces hospital mortality
por: Garnacho-Montero, José, et al.
Publicado: (2015)

Growth and Geographic Variation in Hospitalizations with Resistant Infections, United States, 2000–2005
por: Zilberberg, Marya D., et al.
Publicado: (2008)

Increase in Adult Clostridium difficile–related Hospitalizations and Case-Fatality Rate, United States, 2000–2005
por: Zilberberg, Marya D., et al.
Publicado: (2008)

Timing of adequate antibiotic therapy is a greater determinant of outcome than are TNF and IL-10 polymorphisms in patients with sepsis
por: Garnacho-Montero, Jose, et al.
Publicado: (2006)

Outcomes in participants with ventilated nosocomial pneumonia and organ failure treated with ceftolozane/tazobactam versus meropenem: a subset analysis of the phase 3, randomized, controlled ASPECT-NP trial
por: Martin-Loeches, Ignacio, et al.
Publicado: (2023)

Optimizing antibiotic therapy in the intensive care unit setting
por: Kollef, Marin H
Publicado: (2001)

Bench-to-bedside review: Understanding the impact of resistance and virulence factors on methicillin-resistant Staphylococcus aureus infections in the intensive care unit
por: Skrupky, Lee P, et al.
Publicado: (2009)

Augmented renal clearance is not a risk factor for mortality in Enterobacteriaceae bloodstream infections treated with appropriate empiric antimicrobials
por: Burnham, Jason P., et al.
Publicado: (2017)

Antibiotics for the critically ill: more than just selecting appropriate initial therapy
por: Kollef, Marin H
Publicado: (2013)

Characteristics and outcomes among a hospitalized patient cohort with Streptococcus pneumoniae infection
por: Micek, Scott T., et al.
Publicado: (2020)

A Case-Control Study Assessing the Impact of Nonventilated Hospital-Acquired Pneumonia on Patient Outcomes
por: Micek, Scott T., et al.
Publicado: (2016)

Assessment of Antibiotic De-escalation by Spectrum Score in Patients With Nosocomial Pneumonia: A Single-Center, Retrospective Cohort Study
por: Ilges, Dan, et al.
Publicado: (2021)

Topical honey: for bears, not for ICU catheters?
por: Timsit, Jean-François
Publicado: (2013)

339 An International, Multicenter, Retrospective Study of Nosocomial Pneumonia due to Pseudomonas aeruginosa
por: Micek, Scott, et al.
Publicado: (2014)

Pathogen-Negative Sepsis—An Opportunity for Antimicrobial Stewardship
por: Lockhart, Gabriel C, et al.
Publicado: (2019)

Empiric/pre-emptive anti-Candida therapy in non-neutropenic ICU patients
por: Timsit, Jean-François, et al.
Publicado: (2015)

Enhanced antimicrobial de-escalation for pneumonia in mechanically ventilated patients: a cross-over study
por: Trupka, Tracy, et al.
Publicado: (2017)

Cluster analysis to define distinct clinical phenotypes among septic patients with bloodstream infections
por: Guilamet, Maria Cristina Vazquez, et al.
Publicado: (2019)

Determinants of Mortality for Ventilated Hospital-Acquired Pneumonia and Ventilator-Associated Pneumonia
por: Motowski, Hayley, et al.
Publicado: (2023)

1008. Cluster Analysis to Define Distinct Clinical Phenotypes Among Septic Patients With Bloodstream Infections
por: Guillamet, M Cristina Vazquez, et al.
Publicado: (2018)

How to treat VAP due to MDR pathogens in ICU patients
por: Garnacho-Montero, José, et al.
Publicado: (2014)

1477. Impact Of Resistance Thresholds On Mortality In Hospital-Acquired And Ventilator-Associated Pneumonia
por: Mazi, Patrick B, et al.
Publicado: (2020)

Candidemia on presentation to the hospital: development and validation of a risk score
por: Shorr, Andrew F, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_qgj73o5tk0ft6q2dk8ei7ue9er